新济医药、翼菲科技等拟香港IPO获中国证监会接收材料

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has released a report on the status of domestic companies' overseas securities issuance and listing applications, indicating several companies are preparing for initial public offerings (IPOs) in Hong Kong as of January 30, 2026 [1]. Group 1: Companies Preparing for IPOs - Guangzhou New Ji Pharmaceutical Co., Ltd. is applying for a direct overseas listing on the Hong Kong Stock Exchange, with Guotai Junan Securities as the sponsor [3]. - Zhejiang Yifei Intelligent Technology Co., Ltd. is also seeking a direct overseas listing on the Hong Kong Stock Exchange, with Agricultural Bank of China International as the sponsor [3]. - Guangdong Daoyuan Technology Co., Ltd. plans a direct overseas listing on the Hong Kong Stock Exchange, with China International Capital Corporation and CITIC Securities (International) as sponsors [3]. - Wuxi Cheliantianxia Intelligent Technology Co., Ltd. is preparing for a direct overseas listing on the Hong Kong Stock Exchange, with Haitong International Capital as the sponsor [3]. - Beijing Weimai Medical Technology Co., Ltd. is applying for a direct overseas listing on the Hong Kong Stock Exchange, with China International Capital Corporation as the sponsor [3]. - Shenzhen Jingwang Electronics Co., Ltd. is also seeking a direct overseas listing on the Hong Kong Stock Exchange, with Guolian Securities International Limited as the sponsor [3]. - Shanghai Junsai Biotechnology Co., Ltd. is preparing for a direct overseas listing on the Hong Kong Stock Exchange, with CITIC Securities (Hong Kong) as the sponsor [3]. - Mainline Technology (Beijing) Co., Ltd. is applying for a direct overseas listing on the Hong Kong Stock Exchange, with Guotai Junan Securities as the sponsor [3]. Group 2: Companies with Other Listing Status - Laoxiangji (indirect overseas listing) is in the application process for a Hong Kong IPO, currently in the opinion solicitation stage [1]. - Chipmai Semiconductor Technology (Hangzhou) Co., Ltd. is in the process of submitting supplementary materials for its Hong Kong IPO application [1].

新济医药、翼菲科技等拟香港IPO获中国证监会接收材料 - Reportify